There is a distinct correlation between the concentration of sugar in the blood level of C level occurrence of diabetic foot syndrome. Treatment with drugs that eliminate insulinrezistentnost in Russia currently applies only in a small number of patients, in most cases, surgical treatment of diabetic foot. The search for new and effective methods of sustained therapeutic effect, more cost-effective and devoid of side effects, effects on the body remains relevant. One of these methods may be intravenous laser irradiation of blood with frequency λ=532 nm, this study confirms the effectiveness of its application. As shown by the experimental data, to the use of intravenous laser blood irradiation intravenous laser ir-radiation of blood indicators of glucose in the study and control groups was higher than normal. After the intra-venous laser irradiation of blood these figures were significantly reduced in the intervention group and the con-trol group showed a tendency to preserve the performance on the data at the beginning of the study. The study suggests that the inclusion of therapy intravenous laser irradiation of blood "blue" laser with a wavelength of 532 nm in patients with diabetic foot has a positive impact on the index of blood glucose. The foregoing gives rise to the following conclusions: in patients with diabetic foot syndrome was a significant in-crease in blood glucose therapy in the form of intravenous laser irradiation of blood "blue" laser with a wave-length of 532 nm significantly reduces the level of glucose
diabetes, diabetic foot, a blue laser.
1. Balabolkin M.I. Diabetologiya. M.: Meditsina, 2000.
2. Young M.J. Classification of ulcers and its relevance to management. In: A.J.M. Boulton, H. Connor, P. Canavagh. The Diabetic Foot (3d ed). Wiley 2000, S. 61–72.
3. Dedov I.I. Novye tekhnologii v diagnostike i lechenii patologii pochek pri sakharnom diabete. Materialy Vserossiyskogo kongressa «Diabet i pochki». M., 2009, S. 25–28.
4. Dibirov M.D., Briskin B.S. Khirurgicheskoe lechenie oslozhneniy diabeticheskoy angiopatii. M.. 2001, 321s.
5. Amos A.F., McCarty D.G., Zimmet P. The rising global burden of diabetes and its complications: es-timates and projections to the year 2010. Diabet Med. 1997. 14: (Suppl) 5. S. 1–85.
6. Armstrong D.G., Frykberg R.G. Classifying diabetic foot surgery: toward a rational definition. Diabet Med. 2003. V. 20. P. 329–331.
7. Armstrong D.G., Lavery L.A. Negative pressure Wound after parcial diabetic amputation: a multicen-tre, randomized controlled trial. The Lancet. 2005. V. 366. P. 1704–1710.
8. Banis J.C. Glabrous skin gafts for plantar defects. Foot Ancle Cin (USA). 2001. V.6. № 4. P. 827–837.
9. Boulton A.J., Vinik A.I., Arezzo J.C. Diabetic neuropathies. Diabetes Care. 2005. V. 28. P. 956–962.
10. Bowker J., Pfeifer M. The diabetic foot (Eds.). 6th edition. Mosby, 2001.
11. Bokeriya L.A., Gudkova R.G. Bolezni i vrozhdennye anomalii sistemy krovoobrashcheniya. Serdechno-sosudistaya khirurgiya 2005. M.: NTsSSKh im. A.N. Bakuleva RAMN, 2006. 114 c.
12. Briskin B.S., Proshin A.V. Oslozhnennyy sindrom diabeticheskoy stopy: patogenez, diagnostika i lechenie v pozhilom i starcheskom vozraste. Klinicheskaya gerontologiya. 2004. № 1. S. 33–40.
13. Kokov L.S., Zelenov M.A., Udovichenko A.E. Angiograficheskaya diagnostika, ballonnaya angioplastika i stentirovanie u bol´nykh s diabeticheskoy stopoy. Angiol i sosud khi. 2002. T. 8. № 4. S. 25–32.
14. Mezhdunarodnoe soglashenie po diabeticheskoy stope. M.: Bereg, 2000. 96 s.
15. Obraztsov A.V., Kokhan E.P., Zavarina I.K. Patogeneticheskie aspekty operatsii revaskulyariziruyushchey osteotrepanatsii. Angiol i sosud khir. 2000. T. 6. №1. S. 18–21.
16. Pokrovskiy A.V., Dan V.N., Chupin A.V. Vazaprostan (prostaglandin E1) v kompleksnom lechenii bol´nykh s ishemicheskoy diabeticheskoy stopoy. Angiol i sosud khir. 2000. T. 6. №2. S. 63–72.
